Hybrid Approach for COVID-19 Vaccine Distribution

Authors

DOI:

https://doi.org/10.31181/dma31202546

Keywords:

COVID-19, Proportional-based Distribution, Infection-based Distribution, Hybrid Approach

Abstract

Since December 2019, the entire world has become fully uncontrolled due to the critical and unpredictable nature of the COVID-19 virus. The researchers have proposed various precautionary measures to protect ourselves from it. One of the most established and acceptable tools to control the COVID-19 pandemic is vaccination. Pharmaceutical companies are trying their best to supply vaccines according to requirements within a short period. It has become a challenging task to allocate a limited quantity of vaccines among the state and union territories with respect to multiple aspects. A number of factors are involved and have various impacts on the distribution of vaccines. The impacts of the vaccine distribution factors are estimated using the parameters that are responsible for spreading the COVID-19 infection, such as population density, active cases, infection rate, and total infected persons. In this article, we propose a proportional and infection-based vaccine allocation technique to distribute the vaccine among states or union territories of India based on six COVID-19-related factors to reduce the day-wise infection rate rapidly. Accuracy rate and three distribution grades are used to measure the performance of the proposed methods. Then, a hybrid method is developed by combining the proportional and infection-based vaccine allocation techniques to improve the accuracy rate of the vaccine distribution. Finally, we compare the proportional and infection-based vaccine allocation technique with the hybrid approach, where the hybrid approach performs better.

Downloads

Download data is not yet available.

References

Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., & Chen, H. D. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7

WHO (2020a). WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-mediabriefing-on-2019-ncov-on-11-february-2020 (Last accessed on May 4, 2020)

WHO (2020b). Q&A on coronaviruses (COVID-19). What are the symptoms of COVID-19? https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses (Last accessed on May 11, 2020)

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 323(13), 1239-1242. http://dx.doi.org/10.1001/jama.2020.2648

Liu, K., Chen, Y., Lin, R., & Han, K. (2020). Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of infection, 80(6), e14-e18. http://dx.doi.org/10.1016/j.jinf.2020.03.005

Garg, I., Srivastava, S., Rai, C., Kumar, V., Hembrom, A. A., Ghosh, N., Kumari, B., Bansal, A., & Kumar, B. (2020). Coronavirus (COVID-19): prognostic risk associated with comorbidities and age. International Journal of Recent Scientific Research, 11(04), 37983–37986. http://dx.doi.org/10.24327/ijrsr.2020.1104.5218

Si, A., Das, S., & Kar, S. (2021). Picture fuzzy set-based decision-making approach using Dempster– Shafer theory of evidence and grey relation analysis and its application in COVID-19 medicine selection. Soft Computing, 27, 3327–3341. https://doi.org/10.1007/s00500-021-05909-9

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits (Last accessed on May 4, 2020)

Le, T., Thanh, Z., Andreadakis, A., Kumar, R., Gómez, R., Tollefsen, S., & Saville, M. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19 (5), 305–06. http://dx.doi.org/10.1038/d41573-020-00073-5

Matrajt, L., Eaton, J., Leung, T., & Brown, E. R. (2021). Vaccine optimization for COVID-19: Who to vaccinate first?. Science Advances, 7(6), eabf1374. http://dx.doi.org/10.1126/sciadv.abf1374

Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines, Interim Guidance, WHO, 2020. (Last accessed on May 4,2020). https://iris.who.int/handle/10665/336603

Burke, R. M., Midgley, C. M., Dratch, A., Fenstersheib, M., Haupt, T., & Holshue. M. (2020). Active monitoring of persons exposed to patients with confirmed COVID-19 - United States. MMWR, 69(9), 245-246. http://dx.doi.org/10.15585/mmwr.mm6909e1

https://covid19.who.int/table (Last accessed on May 4, 2020)

https://indianexpress.com/article/explained/explained-infections-after-vaccination-7286616 (Last accessed on 4, 2020)

https://censusindia.gov.in/2011census/censusinfodashboard/index.html (Last accessed on May 4, 2020)

www.seruminstitute.com/pdf/covishield_ChAdOx1_nCoV19_corona_virus_vaccine_insert.pdf (Last accessed on 4, 2020)

http://dx.doi.org/10.1016/j.habitatint.2020.102230www.bharatbiotech.com/images/covaxin/covaxin-fact-sheet.pdf (Last accessed on May 4, 2020)

Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020). Presymptomatic transmission of SARS-CoV-2. Singapore. MMWR, 69(14), 411-415. http://dx.doi.org/10.15585/mmwr.mm6914e1

Mishra, S. V., Gayen, A., & Haque, S. M. (2020). COVID-19 and urban vulnerability in India. Habitat international, 103, 102230.

Sun, X., Andoh, E. A., & Yu, H. (2021). A simulation-based analysis for effective distribution of COVID-19 vaccines: A case study in Norway. Transportation Research Interdisciplinary Perspectives, 11, 100453. http://dx.doi.org/10.1016/j.trip.2021.100453

Oliveira, C., Pereira, J., Santos, E., Lima, T. M., & Gaspar, P. D. (2023). Optimization of the COVID-19 Vaccine Distribution Route Using the Vehicle Routing Problem with Time Windows Model and Capacity Constraint. Applied System Innovation, 6(1), 17. https://doi.org/10.3390/asi6010017

Asllani, A., & Trimi, S. (2022). COVID-19 vaccine distribution: exploring strategic alternatives for the greater good. Service Business, 16(3), 601-619. https://doi.org/10.1007/s11628-022-00497-6

Dan, S., Garai, A., & Biswas, S. (2022, April). Analyzing Lung Diseases Using CNN from Chest X-ray Images. In International Conference on Computational Intelligence in Pattern Recognition (pp. 197-207). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-3734-9_17

Munguía-López, A. C., & Ortega, J. M. P. (2021). Fair Allocation of Potential COVID-19 Vaccines Using an Optimization-Based Strategy. Process Integration and Optimization for Sustainability, 5, 3–12. http://dx.doi.org/10.1007/s41660-020-00141-8

Bhadra, A., Mukherjee, A., & Sarkar, K. (2021). Impact of population density on Covid-19 infected and mortality rate in India. Modeling earth systems and environment, 7(1), 623-629. http://dx.doi.org/10.1007/s40808-020-00984-7

Si, A., Das, S. & Kar, S. (2023). Preferred hospitalization of COVID-19 patients using intuitionistic fuzzy set-based matching approach. Granular Computing, 8, 525–549. https://doi.org/10.1007/s41066-022-00339-w

Si, A., Das, S., & Kar, S. (2019). An approach to rank picture fuzzy numbers for decision making problems. Decision Making: Applications in Management and Engineering, 2(2), 54–64. https://doi.org/10.31181/dmame1902049s

Bray, J. H., & Maxwell, S. E. Introduction to Multivariate Analysis of Variance. Multivariate Analysis of Variance, 7-13. https://doi.org/10.4324/9780429350863-10

Ruan, J., Shi, P., Lim, C. C., & Wang, X. (2015). Relief supplies allocation and optimization by interval and fuzzy number approaches. Information Sciences, 303, 15–32. https://doi.org/10.1016/j.ins.2015.01.002

Sengupta, A., & Pal, T. K. (2000). On comparing interval numbers. European Journal of Operational Research, 127(1), 28-43. https://doi.org/10.1016/S0377-2217(99)00319-7

Published

2024-07-13

How to Cite

Si, A., Das, S., & Kar, S. (2024). Hybrid Approach for COVID-19 Vaccine Distribution . Decision Making Advances, 3(1), 1–17. https://doi.org/10.31181/dma31202546